Eli Lilly is trading 3.02% up at $1,192.45, outperforming a weaker broader market as healthcare stocks draw defensive buying. - Healthcare is up 1.25%, with elevated Treasury yields and economic concerns supporting defensive-sector appeal. - Eli Lilly and insitro announced that machine-learning models are available to select biotech companies through Lilly TuneLab; reporting does not establish this as the cause of the intraday gain.